NASDAQ:STML - Stemline Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$13.00 -0.36 (-2.69 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$13.36
Today's Range$12.85 - $13.37
52-Week Range$7.82 - $20.55
Volume458,039 shs
Average Volume750,361 shs
Market Capitalization$413.41 million
P/E Ratio-4.35
Dividend YieldN/A
Beta1.12

SEC Filings

Stemline Therapeutics (NASDAQ:STML) SEC Filings

DateFilerForm TypeView
03/15/2019
8:01 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
8:00 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
8:00 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
4:08 PM
Stemline Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
03/15/2019
3:17 PM
Stemline Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/08/2019
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/08/2019
8:30 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/08/2019
8:30 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
8:10 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
8:10 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
8:09 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/22/2019
3:38 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
View Filing
02/15/2019
8:31 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
9:17 AM
Polar Capital LLP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
View Filing
02/14/2019
6:49 AM
Consonance Capital Management LP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/13/2019
12:49 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/08/2019
7:58 PM
Bergstein Ivan (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/08/2019
7:56 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
7:54 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
7:52 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
7:50 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/16/2019
3:15 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/16/2019
3:11 PM
Stemline Therapeutics (Filer)
Form 424B5
View Filing
01/15/2019
5:06 AM
Stemline Therapeutics (Filer)
Form 424B5
View Filing
01/11/2019
8:30 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
3:42 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2018
7:59 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/08/2018
3:05 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/14/2018
8:58 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/14/2018
8:58 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/13/2018
6:33 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/10/2018
10:16 AM
FMR LLC (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
08/09/2018
3:16 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/02/2018
4:02 PM
Stemline Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
06/26/2018
7:30 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/22/2018
8:31 PM
Stemline Therapeutics (Issuer)
ZUERBLIS KENNETH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:31 PM
Sard Mark (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:31 PM
HUME DANIEL (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:30 PM
Forman Alan S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:30 PM
Cline Darren S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:30 PM
BENTSUR RON (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:30 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2018
3:30 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/10/2018
6:59 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2018
8:03 AM
Stemline Therapeutics (Filer)
Form DEFA14A
View Filing
04/30/2018
8:00 AM
Stemline Therapeutics (Filer)
Form DEF 14A
View Filing
04/26/2018
5:03 PM
HUME DANIEL (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/26/2018
5:02 PM
Cline Darren S (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/26/2018
5:02 PM
Sard Mark (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/17/2018
6:00 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/16/2018
4:25 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/16/2018
4:24 PM
Stemline Therapeutics (Filer)
Form 424B5
View Filing
03/16/2018
4:20 PM
Stemline Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/16/2018
7:00 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
8:30 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
8:30 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
8:30 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/09/2018
8:32 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/09/2018
8:31 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/09/2018
8:31 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
8:32 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
8:32 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
8:31 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
3:08 PM
Bergstein Ivan (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/14/2018
9:20 AM
Consonance Capital Management LP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
View Filing
02/13/2018
2:40 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/12/2018
9:01 AM
FMR LLC (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/09/2018
12:16 PM
BlackRock Inc. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
View Filing
02/01/2018
8:27 AM
BlackRock Inc. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
View Filing
01/24/2018
3:03 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/24/2018
3:02 PM
Stemline Therapeutics (Filer)
Form 424B5
View Filing
01/19/2018
8:30 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/12/2018
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
6:58 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
3:26 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel